Dry Eye Syndrome Clinical Trial
Official title:
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
To determine if the types and amount of bacteria or other germs change over time after the routine procedure of blockage of tear drainage duct in the treatment of dry eye condition or other condition benefiting from a tear drainage blockage
This study will investigate the impact of punctal occlusion on the ocular microbial flora.
Current thought is that punctal occlusion causes retention of inflammatory mediators on the
ocular surface which may produce pathology, we hypothesize that blockage of the nasolacrimal
drainage system may allow colonization of the ocular surface by potentially pathogenic
ubiquitous organisms (which may produce exotoxins and other biologic products) that may be
responsible for signs and symptoms seen in some patients. Additionally, the presence of the
silicone foreign body(punctal plug) may act as a nidus for bacterial adhesion with biofilm
production (which is known to occur with Pseudomonas sp and other organisms). There would
thus be a paradigm shift of our current understanding of the pathophysiology of punctal
occlusion. Additionally, the choice of antimicrobials for the treatment of infections in
patients with punctal occlusion may need to be modified if the microbial flora is found to
be different in patients with punctal occlusion.
The ocular flora may be different inpatients with severe dry eye or other chronic pathologic
conditions, which are frequent indications for punctal occlusion. However, from our
retrospective review, we could not determine if there was a change in the microbial flora
following plug placement with colonization with these "unusual organisms" since baseline
cultures prior to punctal plug placement were not obtained.
We will try to differentiate any effect on the microbial flora caused by the silicone plug
or acrylic plug(as a foreign body) versus the punctal closure by thermocautery. (Punctal
thermocauterization is an alternative method of punctal closure which is 1) the preferred
choice by some ophthalmologists for all their cases, or 2) when the dry eye is severe and
irreversible punctal occlusion is desired or 3) if punctal plugs can not be retained due to
the large size of the patients punctal). The thermodynamic hydrophobic acrylic
plug(SmartPLUG) approved by the FDA for punctal occlusion with the same indications as the
traditional silicone plug.
;
Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02597803 -
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
|
Phase 2/Phase 3 | |
Completed |
NCT02522312 -
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
|
N/A | |
Completed |
NCT01863368 -
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
|
N/A | |
Completed |
NCT01753752 -
Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation
|
Phase 2 | |
Completed |
NCT01753687 -
Correlation of Different Signs for Assessment of Dry Eye Syndrome
|
N/A | |
Completed |
NCT01212471 -
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
|
Phase 3 | |
Completed |
NCT01198782 -
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
|
Phase 4 | |
Completed |
NCT01162954 -
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00544713 -
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
|
N/A | |
Completed |
NCT00535054 -
Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
|
N/A | |
Completed |
NCT00344721 -
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
|
N/A | |
Completed |
NCT03830359 -
Efficacy, Safety of T2769 in Dry Eye Disease
|
N/A | |
Completed |
NCT04139122 -
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02758327 -
Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops
|
Phase 4 | |
Completed |
NCT01970917 -
Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects
|
Phase 4 | |
Completed |
NCT02066051 -
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD
|
N/A | |
Completed |
NCT02092207 -
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
|
Phase 2 | |
Completed |
NCT01541891 -
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
|
Phase 2 | |
Completed |
NCT01252121 -
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
|
N/A | |
Completed |
NCT00765804 -
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
|
Phase 2 |